COMMUNIQUÉS West-GlobeNewswire

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/10/2024
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/10/2024
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation
07/10/2024
Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]
EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation
07/10/2024
Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]
Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions
07/10/2024
Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions Fleurieux-sur-l’Arbresle - France - le 7 octobre 2024 à 18h . Safe SA (FR001400F1V2 – ALSAF), spécialiste dans la conception [...]
Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024
07/10/2024
Precision Neuroscience’s Cortical Surface Array unlocks an unprecedented view of neural patterns, poised to revolutionize neural decoding NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Researchers shared groundbreaking [...]
CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques
07/10/2024
Abstract to be presented at the 5 th annual HIV Research for Prevention Conference Study results highlight potential for treatment VANCOUVER, Washington, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (" [...]
Colateral completes acquisition of Turbyne creating the first retail media operating system designed for in-store, that integrates with all channels and partners
07/10/2024
TRURO, United Kingdom, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Colateral , a retail marketing platform, announced today the acquisition of Turbyne, a Delaware-based provider of omnichannel Retail Media capabilities, in a [...]
The JDRF Ride to Defeat Diabetes brings corporate Canada together to pedal for a cure for type 1 diabetes
07/10/2024
TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- One of Canada’s longest running and top fundraising events will be taking place in Montréal, QC and Toronto, ON on October 10 and 17 respectively. The JDRF Ride to Defeat [...]
Le Roulons pour vaincre le diabète FRDJ rassemble les entreprises canadiennes pour pédaler vers la guérison du diabète de type 1
07/10/2024
TORONTO, 07 oct. 2024 (GLOBE NEWSWIRE) -- L'un des événements de collecte de fonds les plus anciens et les plus importants du Canada aura lieu à Montréal (Québec) et à Toronto (Ontario) les 10 et 17 octobre [...]
Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile
07/10/2024
Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. (“Oramed”), are expected to participate in the $50 million convertible note offering, which is expected to close on or about [...]
Curia Unveils Brand Refresh at CPHI WW in Milan
07/10/2024
The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and biologics ALBANY, N.Y., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, [...]
New York Medical Device Development Legacy Company MIDI Expands to Toronto
07/10/2024
MIDI is expanding to Toronto to join Canada’s largest MedTech ecosystem, celebrating over 50 years of medical device development excellence TORONTO , Oct. 07, 2024 (GLOBE NEWSWIRE) -- MIDI , a leader in medical device [...]
Sanara MedTech Inc. Announces Changes to Its Board of Directors
07/10/2024
FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving [...]
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day
07/10/2024
MIAMI, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
07/10/2024
LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that [...]
Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)
07/10/2024
BMF-219 is an investigational oral covalent menin inhibitor developed to regenerate insulin-producing beta cells Two trial-in-progress oral presentations to feature Phase II study design of oral covalent menin inhibitor [...]
Revolution Medicines to Deliver Multiple Presentations at the 2024 AACR-NCI-EORTC Symposium and Host Investor Webcast
07/10/2024
Pancreatic ductal adenocarcinoma (PDAC) data from RMC-6236 (RAS(ON) multi-selective inhibitor) and RMC-9805 (RAS (ON) G12D-selective inhibitor) monotherapy studies to be featured in two late-breaking presentations [...]
VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland
07/10/2024
— QSIVA now available in all Scandinavian countries — AMSTERDAM, Oct. 07, 2024 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, today announced the availability of QSIVA ® (phentermine and topiramate modified- [...]

Pages